An opinion piece in the New England Journal of Medicine complains about the limitations of evidence-based medicine (EBM) and recommends a new approach they call "interpersonal medicine." In my opinion, good clinical medicine is already interpersonal medicine; there is no need for something new.
Over the last few years, AORN and the American College of Surgeons have been battling it out over AORN's 2014 guideline that has increasingly led to the banning of the surgical skull cap in the operating room in favor of the bouffant cap. Lacking from this kerfuffle has been much in the way of evidence to support AORN's guideline, but unfortunately that...
The effort of integrative medicine advocates to co-opt the opioid crisis to claim non pharmacological treatments for pain as solely theirs continues apace
Last week, I wrote about how advocates for quackery were trying, and succeeding, at persuading state Medicaid agencies to pay for acupuncture for pain. This week, I discuss how they are promoting the integration of quackery with medicine. In this case, they are promoting a white paper and trying to influence the AHRQ.
Contaminated products from compounding pharmacies have harmed and even killed patients. Quality control measures are being implemented, but there is a bigger problem: the injudicious use of untested and potentially dangerous treatments.
Medical research has been plagued by less-than-rigorous practices and a culture that rewards quantity over quality. In a new book, Richard Harris identifies the problems, proposes solutions, and offers hope.
A preference to use CAM before seeking medical advice may be harming patients with inflammatory arthritis.
Retractions of scientific studies do not always mean that the studies die a deserved death. Sometimes they live on as zombie studies, continuing to be cited by other researchers and having an effect on the scientific discussion. We can fix this.
A recent paper suggests that patients would be better off stopping antibiotics when they feel better, instead of completing the entire amount prescribed. Could this approach reduce antibiotic overuse and the risk of widespread resistance?
A new study suggests that physicians tend to overestimate the benefits of treatments, tests, and screening tests, while also underestimating harms.